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Abstract
To support their replication, viruses take advantage of numerous cellular factors and processes. Recent large-scale screens
have identified hundreds of such factors, yet little is known about how viruses exploit any of these. Influenza virus infection
post-translationally activates P58
IPK, a cellular inhibitor of the interferon-induced, dsRNA-activated eIF2a kinase, PKR. Here,
we report that infection of P58
IPK knockout mice with influenza virus resulted in increased lung pathology, immune cell
apoptosis, PKR activation, and mortality. Analysis of lung transcriptional profiles, including those induced by the
reconstructed 1918 pandemic virus, revealed increased expression of genes associated with the cell death, immune, and
inflammatory responses. These experiments represent the first use of a mammalian infection model to demonstrate the role
of P58
IPK in the antiviral response. Our results suggest that P58
IPK represents a new class of molecule, a cellular inhibitor of
the host defense (CIHD), as P58
IPK is activated during virus infection to inhibit virus-induced apoptosis and inflammation to
prolong host survival, even while prolonging viral replication.
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Introduction
Through a series of signaling mechanisms, the mammalian
innate immune system recognizes and responds to pathogens to
protect the host during infection. The response is initiated when
pathogen-associated molecular patterns (PAMPs), present in
microbial proteins or RNAs, engage cellular pathogen-recognition
receptors (PRRs) such as RIG-I, MDA5, or the toll-like receptors
[1]. Upon engagement, these PRRs activate proteins such as
IRF3, IRF7, and NF-kB, which translocate to the nucleus and
induce the type I interferon (IFN) response [2]. Type I IFNs in
turn induce the expression of numerous IFN-stimulated genes
(ISGs), including IFNc, interleukin (IL)-6, and the dsRNA-
activated protein kinase, PKR [3]. Downstream targets of PKR
include the a subunit of eukaryotic initiation factor 2 (eIF2a), NF-
kB, and additional ISGs [4–6], thus amplifying the IFN response
via a positive feedback mechanism.
P58
IPK is a cellular inhibitor of PKR that is activated at the
post-translational level in response to influenza virus infection [7].
The activation of P58
IPK results in reduced levels of PKR-
mediated eIF2a phosphorylation, which has long been thought to
benefit influenza virus by maintaining a high rate of viral protein
translation [8,9]. P58
IPK is also activated at the transcriptional
level in response to endoplasmic reticulum (ER) stress. During ER
stress, P58
IPK inhibits another eIF2a kinase, PERK, which
functions to regulate protein synthesis during the unfolded protein
response [10,11]. P58
IPK also plays a larger role in the protein
processing efficiency of the ER by binding to misfolded proteins
and acting as a co-chaperone [12–14].
Recently, we showed that influenza virus infection of mouse
embryonic fibroblasts (MEFs) lacking P58
IPK results in increased
eIF2a phosphorylation and decreased viral mRNA translation [8].
This effect was due to P58
IPK functioning through a PKR-
dependent mechanism that is independent of PERK. We also
showed that P58
IPK functions similarly during infection with
vesicular stomatitis virus (VSV) or reovirus. These findings again
suggested that influenza virus benefits from P58
IPK activation,
presumably to the detriment of the host.
Here, we sought to determine for the first time the role of
P58
IPK using an in vivo virus infection model. To this end, we
infected mice lacking P58
IPK with either the mouse-adapted A/
PR/8/34 (PR8) strain or the reconstructed 1918 (r1918) pandemic
influenza virus. We then examined viral replication, lung
pathology, PKR and eIF2a phosphorylation, cytokine expression,
and global gene transcriptional profiles. We found that influenza
virus infections were more lethal in mice lacking P58
IPK, due to
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P58
IPK plays a role in restoring homeostasis during ER stress
through its interaction with PERK, P58
IPK may function during
virus infection to restore homeostasis during the antiviral and
inflammatory response through its interaction with PKR. Our
findings suggest that P58
IPK represents a new class of molecule
that is activated during virus infection to help regulate the host
antiviral response. While a number of host proteins exist which are
crucial in determining the antiviral response, P58
IPK is the first to
be identified in a mammalian system which inhibits the defense
response for proper development of the antiviral state. We coin
this new class of regulators ‘‘Cellular Inhibitors of the Host
Defense’’ (CIHDs).
Results
P58
IPK2/2 mice exhibit a higher influenza virus-induced
mortality rate
To determine the role of P58
IPK using a bona fide mammalian
infection model, we infected P58
IPK2/2 and wild-type mice with a
series of doses (10
1 to 10
5 PFU) of the PR8 strain of influenza
virus. Although P58
IPK2/2 and wild-type mice exhibited similar
weight loss (morbidity) over time (data not shown), mortality was
markedly increased in P58
IPK2/2 mice. This phenotype was
particularly pronounced at lower infectious doses (Figure 1A).
When infected with 10
2 PFU, all P58
IPK2/2 mice died by day 5,
whereas only 33% of wild-type mice died by day 6, and the others
recovered. This corresponded to a fifty percent lethal dose (LD50)
of 10
1.3 PFU for P58
IPK2/2 mice and 10
2.0 PFU for wild-type
mice. The increased mortality in P58
IPK2/2 mice was not due to
increased viral load, since viral titers in the lungs of all infected
mice were similar at each time point (Figure 1B). Furthermore,
mortality was not caused by viral attachment or initial infection
alone, since experiments with a replication-deficient virus
(PR8DNS1) [15] did not produce disease in either mouse genotype
(data not shown).
While both P58
IPK2/2 and wild-type mice exhibited great lung
pathology when infected with high doses of PR8, microscopic
examination revealed increased lung pathology in P58
IPK2/2
mice, as compared to wild-type mice, infected with a lower dose of
PR8. This was marked by moderate to severe alveolitis and
peribronchiolitis, macrophage and neutrophil infiltration, and
associated hemorrhage and edema (Figure 2A). By contrast, wild-
type mice had mild alveolitis and peribronchiolitis with lower
levels of neutrophils, where infiltration of inflammatory cells is
scant (Figure 2B). Alveolitis was observed as early as day 1 post
infection in P58
IPK2/2 mice and inflammation increased in
severity until day 5 (Figure S1). Other histological features which
were more pronounced in P58
IPK2/2 mice were multifocal
intraluminal inflammation with necrotic debris and the formation
of hyaline membranes adjacent to alveolar walls (Figure 2C–D).
Staining for the macrophage marker F4/80 revealed the presence
of greatly increased numbers of macrophages in the lungs of
infected P58
IPK2/2 mice as compared with wild-type mice
(Figure 2E–F). The presence of macrophages was observed by
day 1 post infection in P58
IPK2/2 mice, whereas their presence
was not detected until day 3 post infection in wild-type mice
(Figure S2).
Even though there was increased pathology in the lungs of
infected P58
IPK2/2 mice, a similar number of cells stained positive
for influenza virus NP in both P58
IPK2/2 and wild-type mice
(Figure 2G–H) throughout the course of infection (Figure S3).
Thus, differences in pathology did not appear to be due to
differences in the amount of virus present in lung cells.
Influenza virus infection can induce apoptosis [16], and more
specifically, the caspase cascade can be activated through the
Figure 1. P58
IPK2/2 mice exhibit increased mortality to
influenza virus infection yet similar levels of virus replication.
(A) Three P58
IPK2/2 and wild-type mice were infected with 10 or 100
PFU of the PR8 strain of influenza virus. The number of surviving mice,
as determined by having at least 20% of starting weight, at each day is
shown. (B) Three P58
IPK2/2 and wild-type mice infected with 10
3 PFU of
PR8 were sacrificed at 1, 3, or 5 days post infection. Levels of infectious
virions in diaphragmatic lung homogenates were determined by
triplicate plaque assay on MDCK cells. The results represent the mean
activity of 3 independent samples6standard deviation.
doi:10.1371/journal.ppat.1000438.g001
Author Summary
Respiratory illness caused by influenza virus is the seventh
leading cause of death in the United States, and there is
considerable interest in determining how the virus and
host interact during infection and how the virus causes
disease. Because influenza virus encodes only eight genes,
it is dependent upon cellular proteins and processes for
the generation of new viruses. One of these proteins is
P58
IPK, the activation of which has long been thought to
be required for efficient viral replication. To study how
P58
IPK affects the ability of influenza virus to replicate and
cause disease, we infected a strain of mice that lacks the
gene for P58
IPK. We found that viruses replicated just as
efficiently in mice lacking the P58
IPK gene, but that these
mice were more susceptible to a fatal infection. The
increased mortality rate in these mice was due to greater
lung pathology and a heightened inflammatory response.
Our results show that P58
IPK represents a new type of
protein that benefits the host by reducing pathology and
prolonging survival, even though it may also benefit the
virus by allowing it to replicate for a longer period of time.
P58
IPK Modulates the Innate Immune Response
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induced in the lungs of P58
IPK2/2 mice, we looked for the
presence of cleaved caspase 3. Caspase 3 is downstream of cleaved
caspase 8, and it cleaves other caspases as well as poly(ADP) ribose
polymerase [18]. This analysis revealed increased staining of
cleaved caspase 3 in the lungs of P58
IPK2/2 mice compared with
that detected in wild-type mice (Figure 2I–J), but no cleaved
caspase 3 was observed in the lungs of mock-infected animals
(Figure S4). Increased apoptosis in the lungs of P58
IPK2/2 mice is
consistent with our previous findings that P58
IPK has anti-
apoptotic properties [19]. Our observation of increased apoptosis
and mortality in mice lacking P58
IPK is also consistent with
previous reports of increased apoptosis being a marker for fatal
influenza virus infection [20].
P58
IPK2/2 mice exhibit increased levels of eIF2a and PKR
phosphorylation in response to infection
Influenza virus infection of MEFs devoid of P58
IPK results in
increased PKR activation and eIF2a phosphorylation relative to
wild-type MEFs [8]. In the present study, we determined the
amount of eIF2a and PKR phosphorylation in the lungs of
P58
IPK2/2 and wild-type mice infected with PR8. We observed
increased eIF2a phosphorylation in the lungs of influenza
virus-infected P58
IPK2/2 mice throughout infection (Figure 3A).
Figure 2. P58
IPK2/2 mouse lungs exhibit increased pathology during influenza virus infection. P58
IPK2/2 and wild-type (WT) mice were
infected with 10
3 (A,B, E–H), 10
4 (I,J), or 10
5 (C,D) PFU of the PR8 strain of influenza virus and stained for hematoxalin and eosin (H&E) (A,B), periodic
acid-Schiff (PAS) (C,D), F4/80 (E,F), influenza virus NP (G,H), or cleaved caspase 3 (I,J) at 5 days post infection. This shows that, while both P58
IPK2/2
and wild-type mouse lungs contain similar amounts of infected cells, P58
IPK2/2 mice exhibit increased alveolitis and peribrochiolitis, marked by
macrophage and neutrophil infiltration, hyaline membrane formation, and caspase activation. Arrows denote hyaline membranes. Bar=50 mm.
doi:10.1371/journal.ppat.1000438.g002
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was significantly increased in P58
IPK2/2 mouse lungs at days 1
and 3 post infection (Figure 3B). Increased and prolonged eIF2a
phosphorylation is reported to lead to apoptosis [21], which is
consistent with our findings of increased levels of caspase 3
activation and mortality in mice lacking P58
IPK. Further
investigation revealed that there was increased PKR phoshoryla-
tion (Figure 3C–D), but not PERK phosphorylation (data not
shown), in the absence of P58
IPK, resulting in increased eIF2a
phosphorylation.
P58
IPK2/2 mice exhibit increased levels of inflammatory
and immune response genes early after infection
Our traditional virology, histology, and biochemical approaches
indicated that influenza virus infection of P58
IPK2/2 mice was
associated with increased lung pathology characterized by
macrophage infiltration, apoptosis, and increased levels of eIF2a
phosphorylation. Each of these effects have been associated with
severe influenza virus infection [20,22,23]. In order to discover
potentially new mechanisms that might contribute to increased
mortality in mice lacking P58
IPK, we used oligonucleotide
microarrays to profile the host transcriptional response to
infection.
For our microarray analyses, P58
IPK2/2 and wild-type mice
were infected intranasally with 10
3 PFU of PR8, or mock-infected
with PBS alone, and sacrificed at days 1, 3, and 5 post infection.
RNA was then isolated from left lung lobes for gene expression
profiling. Analyses were performed by comparing RNA isolated
from each individual animal against a pool of RNA from
genotype-matched mock-infected animals. To perform a direct
comparison of gene expression profiles of P58
IPK2/2 and wild-
type mice, we used the re-ratio tool in Rosetta Resolver. This tool
creates new ratio experiments from two or more existing ratio
experiments that share a common reference, therefore removing
the reference and focusing on the difference between two
conditions. Next, working with one set of gene expression data
at each time point, we used Gene Set Enrichment Analysis (GSEA)
[24] to identify sets of genes that were differentially expressed
between the P58
IPK2/2 and wild-type mice.
GSEA determines how two distinct phenotypes differ in their
gene expression profiles by ranking the significance of the gene
ontology (GO) sets identified. Given a defined set of genes
annotated with a certain GO function, GSEA determines whether
the members of that set are randomly distributed throughout the
ranked list or if they are found primarily at the top or bottom of
that list. Those sets at the top or bottom of the list describe the
phenotypic distinction between the two sets [24]. While traditional
GO analysis uses a preselected set of genes created using an
arbitrary fold-change or P value cutoff, GSEA examines the entire
gene set [25].
We found that GO categories at the top of the day 3 list were
characterized by the negative regulation of metabolic processes,
whereas those at the top of the day 5 list included a random
assortment of biochemical processes (Figure S5 and Figure S6).
The top of the GSEA list for day 1 included many processes
Figure 3. P58
IPK2/2 mouse lungs exhibit increased eIF2a and PKR phosphorylation during influenza virus infection. Three P58
IPK2/2
and wild-type mice were infected with 10
4 (A,B) or 10
3 (C,D) PFU of the PR8 strain of influenza virus. At 1 and 3 days post infection, azygous and apical
lung lobes were excised and homogenized. (A) Equivalent concentrations of protein in lung homogenates were subjected to SDS-10% PAGE. The
levels of phosphorylated or total eIF2a and actin were determined by immunoblot analysis. (B) Densitometry analysis of (A). The density of the eIF2a-
P band was normalized to the density of the total eIF2a band, which is represented graphically. (C) 400 mg of total protein from lung homogenates
was used for immunoprecipitation with an antibody for total PKR. Following immunoprecipitation, protein samples were clarified by SDS-10% PAGE
and the levels of phosphorylated or total PKR were determined by immunoblot analysis. (D) Densitometry analysis of (C). The density of the P-PKR
band was normalized to the density of the total PKR band, which is represented graphically. The results represent the mean activity of 3 biologically
independent samples6standard deviation. P-values from a two-tailed t-test assuming non-equal variance are indicated (*: P,0.05, **: P,0.05).
doi:10.1371/journal.ppat.1000438.g003
P58
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S7). A subset of GO categories, highlighted in Figure S7, is shown
in Figure 4, and these categories are connected by edges, the
thickness of which corresponds to the number of overlapping
genes in each category. The gene expression data showed a
dramatic increase in chemokine expression in P58
IPK2/2 mice,
which likely resulted in an exaggerated inflammatory response
[26]. Although some gene expression values were low, even small
changes in gene expression can have a drastic effect on biological
function [27]. In addition, GSEA indicated that the GO categories
were significantly perturbed, even if the genes within the categories
were not highly regulated. Together, our gene expression analyses
showed that the absence of P58
IPK during influenza virus infection
caused an increase in inflammatory, immune response, and cell
death-related genes at early times post infection, likely prognostic
of the eventual increased lung pathology and ultimately death.
P58
IPK2/2 mice exhibit increased levels of IL-6 and IFNb
in response to infection
Since genomic profiling indicated an increased inflammatory
response in P58
IPK2/2 mice, we next evaluated whether mice
lacking P58
IPK exhibited increased cytokine abundance at the
protein level. One important cytokine that has been shown to be
over-expressed during fatal influenza virus infection is interleukin-
6 (IL-6) [28]. Using an enzyme-linked immunosorbent assay
(ELISA), we found that IL-6 levels were increased in the lungs of
P58
IPK2/2 mice compared with wild-type animals throughout the
course of infection (Figure 5A). Furthermore, we detected
increased levels of IL-6 in the serum of infected P58
IPK2/2 mice
at day 5 post infection (Figure 5B). This increase in IL-6 protein in
the serum and lungs of infected P58
IPK2/2 mice was accompanied
by a drastic increase in IL-6 mRNA. (Figure 5C). Furthermore,
levels of IFNb mRNA were significantly increased in the lungs of
P58
IPK2/2 mice at day 3 post infection (Figure 5D). IFNb
induction results in the increased production of IL-6 [29], and
together, the expression of these two cytokines suggests that a
greater IFN and cytokine response contributes to the increased
lung pathology and higher mortality rate associated with influenza
virus infection of P58
IPK2/2 mice.
Pandemic influenza virus infection results in an amplified
inflammatory response in P58
IPK2/2 mice
In addition to using P58
IPK2/2 mice to determine the role of
P58
IPK during influenza virus infection, we were also interested in
determining whether these mice could provide new insight into the
unusually high virulence of the virus responsible for the 1918
influenza pandemic. Infection with 5610
6 PFU of r1918 resulted
in the death of all P58
IPK2/2 mice by day 4 post infection and the
death of all wild-type animals by day 7 (Figure 6A). This
corresponded to an LD50 of 10
1.8 PFU for P58
IPK2/2 mice and
10
2.5 PFU for wild-type mice. Similar to PR8, wild-type mice
required five times the dose of r1918 to achieve fifty percent
mortality, as compared to P58
IPK2/2 mice. The increased
mortality of P58
IPK2/2 mice was again not due to differences in
Figure 4. Inflammatory response genes are more up-regulated in influenza virus-infected P58
IPK2/2 mice at 1 day post infection.
Gene Set Enrichment Analysis (GSEA) analysis was performed on a sample set derived from P58
IPK2/2 and wild-type mice infected with the PR8 strain
of influenza virus in triplicate at 1 day post infection. All infected samples were compared to genotype-matched mock-infected samples via
microarrays analysis. Replicate samples were then in silico error-weighted pooled and re-ratioed to compare P58
IPK2/2 gene expression to wild-type
gene expression. Following GSEA analysis using only those genes which were significantly regulated, the top gene ontology categories related to the
immune response were selected (see Figure S7 for entire table). An edge is placed between gene ontology categories if they share common genes,
and the edge’s thickness increases as the number of common genes increases. The log10 ratio of P58
IPK to wild-type gene regulation is noted for
selected gene ontology categories.
doi:10.1371/journal.ppat.1000438.g004
P58
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IPK2/2 and
wild-type mice (Figure 6B). Microscopic examination revealed
lung pathology similar to that reported previously [22,30].
We then used global gene expression profiling to determine the
transcriptional response of P58
IPK2/2 mice to infection with
r1918 and to evaluate similarities and differences in the host
response to r1918 and PR8. We began our analysis by comparing
lung gene expression profiles of r1918-infected and mock-infected
P58
IPK2/2 mice and selecting for genes that were expressed at a
higher level during virus infection. We then determined which
genes among this group were expressed at a lower level in r1918-
infected wild-type mice. Because these genes were induced in
P58
IPK2/2 mice in response to virus infection, but were expressed
at a lower level in virus-infected wild-type mice, the infection-
induced expression of these genes appears to be impacted by the
presence or absence of P58
IPK.
This same analysis path was then used to analyze the gene
expression data generated from the PR8 infections described
above, again resulting in a set of infection-induced genes, the
expression of which appears to be impacted by the presence or
absence of P58
IPK. Of the annotated genes in this set, 65 were also
present in the final set of genes identified from the r1918 virus
infection data. The majority of these genes (47 of 65) are associated
with inflammatory, immune response, and cell-death pathways
and their expression patterns in P58
IPK2/2 and wild-type mice are
shown in Figure 7A. Because these genes were all expressed at a
higher level in P58
IPK2/2 mice, they may therefore be associated
with the increased pathology and mortality rate observed in these
animals. However, of particular interest are the set of genes
present in the middle panel of this Figure, which were induced in
P58
IPK2/2 mice in response to infection with either PR8 or r1918,
but which were induced in wild-type mice only in response to the
r1918 virus. To evaluate the functional relationships of these genes
more closely, we used Ingenuity Pathways Analysis (IPA) to create
a network of the set of genes in the middle of Figure 7A, showing
direct or indirect interactions reported for these cell-death- and
inflammatory-response-related genes (Figure 7B). The network is
centered around tumor necrosis factor (Tnf), which is interesting
because activation of Tnf-related pathways has been shown to be
associated with H5N1 influenza viral infections of macrophages
[31]. This pattern of expression suggests that these genes may also
contribute to the exceptional virulence of the r1918 virus, but,
Figure 5. Mice lacking P58
IPK display increased levels of IL6 and IFNb during influenza virus infection. Three P58
IPK2/2 and wild-type
mice were mock infected or infected with 10
3 (A,B) or 10
4 (C,D) PFU of the PR8 strain of influenza virus. At 1, 3, or 5 days post infection, blood serum
was isolated, azygous and apical lung lobes, or left lung lobes were excised and homogenized. Equivalent concentrations of protein in serum (A) or
azygous and apical lung homogenates (B) were subjected to ELISA using an IL6 antibody. Total RNA was isolated from left lung lobes for reverse
transcription to generate cDNA. Quantitative RT-PCR was used to determine the amount of mouse IL6 (C) and IFNb (D) mRNA in each sample. The
results represent the mean activity of 3 independent samples (with technical triplicates)6standard deviation. P values from a two-tailed t-test
assuming non-equal variance are indicated (*: P,0.05, **: P,0.01, ***: P,1610
24).
doi:10.1371/journal.ppat.1000438.g005
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virulence in animals lacking P58
IPK.
Discussion
In this study, we demonstrate that P58
IPK plays a novel role in
regulating the antiviral and inflammatory responses to influenza
virus infection. Here, we have specifically shown, through detailed
high-throughput and biochemical analysis, how P58
IPK may
protect the host during influenza virus infection. In previous
reports, we demonstrated that P58
IPK is activated upon infection
with influenza virus [32] and that P58
IPK binds to and inhibits
PKR [7,33]. We also showed that cells devoid of P58
IPK exhibit
higher levels PKR activation and eIF2a phosphorylation, yet
lower levels of viral mRNA translation during influenza virus
infection [8]. Together, these results suggest that P58
IPK activation
is required for more efficient influenza virus replication in vitro and
that the virus usurps P58
IPK activation to the detriment of the host.
However, our current study has expanded and changed our
understanding of how the activation of P58
IPK impacts viral
replication since we have now shown that the absence of P58
IPK
did not affect levels of viral load in vivo, although we did not
examine rates of viral replication. Nevertheless, influenza virus
infection in P58
IPK2/2 mice resulted in increased mortality due to
a heightened inflammatory response marked by increased lung
pathology and apoptosis. Furthermore, at the lowest doses of
influenza virus, wild-type mice recovered from infection, suggest-
ing that P58
IPK benefits the host during infection.
Our findings provide the first direct evidence that P58
IPK is a
regulator of the host innate immune response repertoire and that
activation of P58
IPK results in decreased lung pathology and host
mortality. A model describing these results is presented in Figure 8,
which is divided into two categories: the apoptotic and
inflammatory responses. P58
IPK functions through each via its
inhibition of PKR. P58
IPK inhibits the apoptotic response via its
inhibition of PKR-mediated caspase activation and eIF2a
phosphorylation. P58
IPK also inhibits the inflammatory response
via its inhibition of PKR-mediated NF-kB activation, which
ultimately activates IFN-stimulated genes. Therefore, P58
IPK is
necessary to counterbalance the activities of PKR, and together,
the over-activation of pathways downstream of PKR results in
increased host pathology and mortality [20,28]. While our analysis
revealed that neither PERK nor its downstream targets were
activated during influenza virus infection, we regard these negative
results as inconclusive due to the difficultly in performing these
experiments, especially with regard to sample preparation [34].
Since influenza virus hemagglutinin has been shown to cause ER
stress [35], we are performing experiments with more sensitive
assays to look for markers of ER stress in influenza virus-infected
mice.
There is evidence of a connection between PKR and proteins
involved in apoptosis, namely FADD and caspase 8 [36,37], and
PKR may engage a death receptor that is upstream of caspase 8
activation and apoptosis. Although a definite connection between
PKR and FADD-mediated caspase 8 activation remains to be
determined, apoptosis is induced by the over-expression of PKR
[38]. Additionally, caspase 8 activation results in caspase 3
activation, resulting in apoptosis [39]. Fas ligand (FasL), Tnf, and
caspases 1 and 7, which activate caspases 8 and 3 [40–43], were
identified in our microarray analysis as being more up-regulated in
P58
IPK2/2 mice during influenza virus infection. We also
previously demonstrated that P58
IPK is anti-apoptotic, as nude
mice injected with cells over-expressing P58
IPK undergo malignant
transformation [19]. Finally, P58
IPK2/2 mice, which have basal
levels of ER stress [12,13], exhibit increased caspase 3 activation
and apoptosis of b-cells in the pancreas [44]. We have now shown
that the stimulus of influenza virus infection in lung tissue
contributes to increased apoptosis in the absence of P58
IPK. This
was marked by increased and prolonged eIF2a phosphorylation
[21] and increased caspase 3 activation in the lungs of these mice.
With respect to the inflammatory response arm of the model,
PKR activates NF-kB, which in turn activates Foxp3, IFNb, and
IFNc, and a number of chemokines [18,45,46]. Each of the
downstream NF-kB responses shown in Figure 8, among many
others, was up-regulated in P58
IPK2/2 mice as compared with
wild-type mice. Again, this is likely due to uncontrolled activation
of PKR in the absence of P58
IPK. Treatment of bronchial
epithelial cells with dsRNA activates both PKR and NF-kB, which
results in the secretion of pro-inflammatory interleukins and
chemokines [47]. This response could lead to increased lung
pathogenesis during a viral infection, which was a striking
difference between influenza virus-infected P58
IPK2/2 and wild-
type mice. While only one lung lobe was analyzed for each mouse,
and neither step sectioning nor bronchoalveolar lavages were
performed, pathogenesis in P58
IPK2/2 mice was marked by
increased macrophage infiltration and hyaline membrane forma-
tion. Hyaline membranes obstruct the exchange of oxygen across
the alveolar walls and is characteristic of diffuse alveolar damage
[48]. It is also a characteristic sign of lethal influenza virus
Figure 6. P58
IPK2/2 mice exhibit increased mortality to
pandemic influenza virus infection yet similar levels of virus
replication. (A) Three P58
IPK2/2 and wild-type mice were infected with
10
5 or 5610
6 PFU of the r1918 strain of influenza virus. The number of
surviving mice, as determined by having at least 20% of starting weight,
at each day is shown. (B) Three P58
IPK2/2 and wild-type mice infected
with 10
4 PFU of r1918 were sacrificed at 3 days post infection. Levels of
infectious virions in diaphragmatic lung homogenates were determined
by triplicate plaque assay on MDCK cells. The results represent the
mean activity of 3 independent samples6standard deviation.
doi:10.1371/journal.ppat.1000438.g006
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PLoS Pathogens | www.plospathogens.org 7 May 2009 | Volume 5 | Issue 5 | e1000438Figure 7. Both PR8 and r1918 infections result in an exaggerated inflammatory response in infected P58
IPK2/2 mice. (A) Venn diagram
analysis was performed on a sample set derived from P58
IPK2/2 and wild-type (WT) mice infected with the PR8 or r1918 strains of influenza virus in
triplicate at 1 day post infection. All infected samples were compared to genotype-matched mock-infected samples via microarrays analysis. Replicate
samples were then pooled and error-weighted in silico. For each virus, a gene set was isolated which included genes which were up-regulated in
P58
IPK2/2 mice as compared to mock and as compared to wild-type mice. The intersection of the sets for both PR8 and r1918 infection was isolated
for IPA. Of the 113 genes in this set, 65 had annotation, and 47 of those had functions related to the inflammatory and cell death responses; log10
ratio regulation of these genes in P58
IPK2/2 and wild-type mice as compared to mock is represented for both viral infections. The bar graph
represents the log10 ratio of P58
IPK2/2 to wild-type gene regulation, showing that each gene is more up-regulated in P58
IPK2/2 mice. (B) IPA network
analysis of the middle set of genes in (A) highlights a subset of genes that are up-regulated in wild-type mice during r1918 infection but not PR8
infection. This diagram shows the direct or indirect interactions reported for these cell-death- (blue shading) and inflammatory-response-related
(yellow shading) genes. Genes shaded orange fit into both categories.
doi:10.1371/journal.ppat.1000438.g007
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infection of macrophages stimulates the release of IL-6 [50], and
we observed an increase in IL-6 mRNA and protein levels in the
lungs of virus-infected P58
IPK2/2 mice due to increased
macrophage infiltration in the lungs of these animals. Increased
levels of IL-6 have also been associated with fatal influenza virus
infections [51,52], which is consistent with the increased mortality
observed in P58
IPK2/2 mice. This is especially significant because
it was at day 5 post infection, when IL-6 levels were highest, that
mice lacking P58
IPK died from infection. IFNb expression has
been shown to be correlated with IL-6 expression during influenza
virus infection and severe acute respiratory syndrome (SARS)-
coronavirus infection [53,54], and IFNb expression was also
elevated in influenza virus-infected P58
IPK2/2 mice.
Antiviral and inflammatory responses are typically necessary to
clear the virus and to recover from infection [55]. However,
during infection with a virus such as Ebola virus, the marked over-
expression of genes associated with the immune and inflammatory
response may contribute to disease pathology and death [56,57].
We have also shown that infection of mice or macaques with
H5N1 avian influenza viruses, or the 1918 pandemic virus, results
in rapid disease and death, most likely due to an early and
dysregulated host inflammatory response, which is associated with
severe lung disease and mortality [22,31,52,58,59]. Our current
genomic profiling data suggest a similar phenomenon is occurring
in P58
IPK2/2 mice infected with influenza virus, where the
significant expression of immune response-related genes at 1 day
post infection was correlated with eventual death of the animal. In
contrast, the expression profiles from wild-type mice exhibited
increased expression of inflammatory response genes, but not until
later times post infection, which was correlated with prolonged
survival. Not only did these observations hold for the mouse-
adapted PR8 virus, but also for the human 1918 pandemic strain.
This is noteworthy, because two strains of influenza virus, each
with different species specificity, produced the same disease
phenotype in P58
IPK2/2 mice via the same pathway. Further-
more, we identified a subset of genes, focused largely around Tnf
and matrix metallopeptidase 3 (Mmp3), which were up-regulated
in wild-type mice only during r1918 infection and not PR8
infection. Although it has been shown that Tnf activation increases
the expression of Mmp3 [60], and that matrix metallopeptidases
are up-regulated in airway epithelium disease in which macro-
phages and eosinophils are highly present [61], it has not
previously been shown that Mmp3 activation is a function of
influenza virus infection. This suggests that even by 1 day post
infection, lung cells are undergoing a remodeling process which
will ultimately lead to pathogenesis and mortality, by a potentially
novel pathway, during pandemic influenza virus infection.
Together, our results show that P58
IPK plays an important role
in regulating the innate immune response, as its presence results in
Figure 8. P58
IPK functions as an inhibitor of the apoptotic and inflammatory responses during influenza virus infections. During
influenza virus infection, P58
IPK and PKR are activated. While P58
IPK-mediated inhibition of PKR results in decreased apoptotic and inflammatory
responses, the absence of P58
IPK results in the amplification of these responses via increased Caspase, eIF2a, and NF-kB activation. Molecules shaded
light grey were up-regulated in infected P58
IPK2/2 mice at the transcript level while those shaded dark grey were up-regulated at the protein level. In
tandem, the enhancement of these responses results in increased mortality in P58
IPK2/2 mice.
doi:10.1371/journal.ppat.1000438.g008
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P58
IPK benefits the host through reduced lung pathology and
prolonged survival, it also provides the virus with additional time to
replicate and spread among other hosts. The results of our study are
therefore somewhat different than those observed in plant virus
infection models, where plants lacking P58
IPK also exhibited
increased host death. Since plants lacking P58
IPK exhibited lower
levels of viral replication, it was concluded that P58
IPK is required
for virulence and acts a susceptibility factor [9]. However, unlike
animals, plants do not invoke cell death as part of their immune
response to virus infection. Since we have shown that in wild-type
mice P58
IPK functions to modulate the innate immune, inflamma-
tory, and cell death responses during viral infection, resulting in
decreased pathology and a lower mortality rate, activation of
mammalian P58
IPK actually functions to reduce the virulence of
influenza virus infection. Thus, we have identified P58
IPK as a new
class ofmoleculethat isactivated duringvirusinfectiontoinhibit the
over-activation of inflammatory and cell death responses in order to
prolong host survival. Further studies as to how to modulate the
P58
IPK pathway, and thus the host’s antiviral and inflammatory
response, may lead to the discovery of novel therapeutics for
targeted intervention during a pandemic influenza virus infection.
Materials and Methods
P58
IPK2/2 mice, viruses, and cells
P58
IPK2/2 mice were 100% C57BL/6 (from a C57BL/6
embryonic stem cell line) and were maintained on the C57BL/6
background by alternate generation backcrossing as previously
described [44]. Mice were maintained in a specific pathogen-free
barrier facility with standard rodent diet and 12 h alternating light
and dark cycles. The PR8 strain of influenza virus was grown in
10-day-old embryonated chicken eggs [62]. The r1918 influenza
virus was generated as previously described [22,30]. Plaque assays
were performed using Madin–Darby canine kidney (MDCK) cells
grown as monolayers in high glucose Dulbecco’s modified Eagle’s
medium supplemented to contain 10% heat-inactivated fetal calf
serum, 2 mM L-glutamine, penicillin G (50 units/ml), and
streptomycin sulfate (50 mg/ml).
Mouse infections
Ten- to twelve-week-old P58
IPK2/2 or wild-type C57BL/6
mice (Charles River Laboratories) were anesthetized with
isoflurane and infected intranasally with 100 ml aliquots of PBS
(control) or PBS containing 10
0 to 10
5 plaque-forming units (PFU)
of the PR8 strain of influenza virus. On days one, three, and five
post infection, three mock-infected and three P58
IPK 2/2 or wild-
type mice infected with 10
3 or 10
4 PFU were sacrificed.
Remaining animals were weighed each day for ten days post
infection and sacrificed when they lost at least 20% of their starting
body weight. Blood and lung tissue was collected from each mouse
at the time of sacrifice. All experiments were performed in a
specially separated negative-pressure HEPA (high-efficiency par-
ticulate air)-filtered biosafety level 2 laboratory. All animals were
handled in strict accordance with good animal practice as defined
by the relevant national and/or local animal welfare bodies, and
all animal work was approved by the University of Washington
Institutional Animal Care and Use Committee. Infections of
P58
IPK2/2 and wild-type C57BL/6 mice with r1918 was
performed as previously described [22].
Plaque assay and protein analysis
Diaphragmatic lung lobes from each animal were weighed,
homogenized in PBS, and samples were then assayed in triplicate
for viral yield by standard plaque assay on MDCK cells. Viral
yields were calculated according to the formula: yieldt=x=
(log10(PFU/ml)t=x)/(log10(PFU/ml)t=0), where t is time and x is
the time post infection.
Azygous and apical lung lobes were homogenized in mammalian
extraction buffer (Pierce) supplemented with 16complete protease
inhibitor (Roche), 25 mM b-glycerophosphate, 1 mM Na3VO4,
and 1 mM NaF. Total protein content was determined for clarified
lung homogenates using the BCA protein assay kit (Pierce).
Homogenates were separated by SDS-PAGE, with the same
amount of total protein being loaded into each lane, and then
transferred to nitrocellulose paper. Immunoblots were blocked for
1 h in PBS containing 0.5% Tween 20 and 5% nonfat dry milk,
washed in PBS containing 0.05% Tween 20, and incubated at 4uC
overnight with rabbit-anti-eIF2a[pS
51] phosphospecific antibody
(Biosource International), a rabbit polyclonal antibody recognizing
full-length eIF2a (Santa Cruz Biotechnology), or a mouse
monoclonal actin antibody (MP Biochemicals) in PBS containing
0.5% Tween 20 and 1% nonfat dry milk. Membranes were washed,
incubated for 2 h with horseradish peroxidase-conjugated donkey
anti-mouse or anti-rabbit immunoglobulin G (Jackson Immunor-
esearch), and bound antibodies detected withECL Western blotting
detection reagent (Amersham Biosciences/GE Healthcare). To
determine levels of PKR and phosphorylated PKR, 400 mg of total
protein from lung homogenates were immunoprecipitated with an
antibody recognizing total PKR (Santa Cruz Biotechnology) for 2 h
at 4uC followed by an overnight incubation at 4uC with Protein A
Sepharose beads (Amersham Biosciences/GE Healthcare). Beads
were washed with NETN buffer (20 mM Tris-HCl, pH 8.0,
100 mM NaCl, 1 mM EDTA, and 0.5% NP-40). Western blotting
was then performed for total PKR (Santa Cruz Biotechnology) and
pT
451 PKR (Invitrogen) as described by the product analysis sheets.
Blood was also collected at the time of sacrifice and serum was
separated by centrifugation. Using equal amounts of total protein
in serum or azygous and apical lung lobe homogenates, absolute
levels of IL-6 were determined by enzyme-linked immunosorbent
assay (ELISA) using the Quantikine assay kit (R&D Systems) as
described by their protocol.
Histopathological, immunohistochemical, and statistical
analysis
Cardiac lung lobes were excised, perfused, and fixed in .10
volumes of 10% neutral-buffered formalin (Fisher Scientific) for
48 h. Paraffin embedding, sectioning, and staining were per-
formed by the Experimental Histopathology Shared Resources at
the Fred Hutchinson Cancer Research Center (Seattle, WA).
4 micron sections of lung were stained with H&E and PAS by
standard methods. Sections were also immunostained for cleaved
caspase 3 and macrophage marker F4/80 as described [63].
Influenza virus NP was detected with a rabbit polyclonal antibody
(a kind gift from Adolfo Garcı ´a-Sastre) at 1:8000 and using the
protocol described for cleaved caspase 3 without antigen retrieval.
To score lung inflammation and damage, a semi-quantitative
scoring system was used; for this, the entire cardiac lobe surface
was analyzed with respect to the following parameters: alveolitis,
peribronchiolitis, and perivasculitis. Each parameter was graded
on a scale of 0–4 with 0 as ‘‘absent,’’ 1 as ‘‘slight,’’ 2 as ‘‘mild,’’ 3 as
‘‘moderate,’’ and 4 as ‘‘severe.’’ The total ‘‘lung inflammation
scor’’ for each mouse lung lobe was determined as the sum of the
scores for each parameter, the maximum being 12. The average,
standard deviation, and P-values from a two-tailed t-test assuming
non-equal variance were determined for each set of triplicate mice
for each genotype. Representative micrographs from the most
significant doses are presented for both genotypes.
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described above was used to score the entire cardiac lobe surface,
except that a scoring system of 0–3 was used with 0 as ‘‘none,’’ 1 as
‘‘infrequent,’’ 2 as ‘‘common,’’ and 3 as ‘‘widespread.’’
Quantitative RT-PCR
Following animal sacrifice, the left lung lobe was homogenized in
Solution D (4 M guanidinium thiocyanate, 25 mM sodium citrate,
0.5% sarcosyl, 0.1 M b-mercaptoethanol), and total RNA was
isolated using RNAeasy (Qiagen). The quantity of total RNA was
determined by spectrophotometry using a NanoDrop ND-1000
Fluorospectrometer. Contaminating DNA was removed by treating
samples with RNAase-free DNase and removal reagents (Ambion).
Reverse transcription was performed using TaqMan reverse
transcription reagents (Applied Biosystems). RT-PCR was per-
formed as previously described [64]. Each target was run in
quadruplicate, with 100 ng of sample in reaction volumes of
TaqMan 26 PCR Universal Master Mix (Applied Biosystems).
Genome copy numbers were normalized to b-actin values
determined in parallel using Taqman gene expression assay
endogenous control primer-probe sets (Applied Biosystems).
Quantification of each gene, relative to the calibrator, was
calculated by the instrument, using the equation 2
DCT(infected)2DCT
(mock) within the Applied Biosystems Sequence Detection Software
version 1.3. The minor groove binding probe and primer sets for
each gene were part of an Applied Biosystems assay set as follows:
Mouse IL6: Mm00446190_m1; Mouse IFNb: Mm00439546_s1.
Expression microarray analysis and bioinformatics
Amplification of mRNA was performed as described previously
using equal masses of total RNA isolated from left lung lobes of
infected mice [57]. An equal-mass pool of mRNA isolated from the
lungs of five individual mock-infected mice was prepared as a
reference sample. Microarray slide hybridization was performed
usingmouseoligonucleotidegenomeCGHarrays(G4426B;Agilent
Technologies). For each infection group, expression oligonucleotide
array analysis was performed using RNA isolated from lung tissue
from three individual animals. The data presented are the error-
weighted average changes in expression calculated from four
technical replicate arrays performed on three individual mice. All
data were entered into a custom-designed relational database and
subsequently uploaded into Rosetta Resolver System 7.1 (Rosetta
Biosoftware), Spotfire Decision Site 9.1 (Spotfire/Tibco), or
Ingenuity Pathways Analysis (Ingenuity Systems, Inc.). Primary
microarray data are available at http://viromics.washington.edu.
Gene set enrichment analysis was performed as described [24]
using only those genes which were significantly regulated and not
taking into consideration the first instance of the maximum
enrichment score. P values were calculated using the dynamic
programming method as described [65].
Supporting Information
Figure S1 Pathology increases at a greater rate in mice lacking
P58
IPK. P58
IPK2/2 and wild-type mice were mock infected or
infected with 10
3 PFU of the PR8 strain of influenza virus. At 1, 3,
and 5 days post infection, cardiac lung lobes were excised and
fixed in 10% neutral-buffered formalin. Lobes were paraffin
embedded, sectioned, and stained for hematoxalin and eosin.
Bar=50 mm.
Found at: doi:10.1371/journal.ppat.1000438.s001 (7.46 MB TIF)
Figure S2 Macrophage infiltration occurs at a greater rate in
mice lacking P58
IPK. P58
IPK2/2 and wild-type mice were mock
infected or infected with 10
3 PFU of the PR8 strain of influenza
virus. At 1, 3, and 5 days post infection, cardiac lung lobes were
excised and fixed in 10% neutral-buffered formalin. Lobes were
paraffin embedded, sectioned, and stained for the macrophage
marker, F4/80. Bar=50 mm.
Found at: doi:10.1371/journal.ppat.1000438.s002 (6.98 MB TIF)
Figure S3 Mice lacking P58
IPK do not exhibit increased levels of
viral protein throughout infection. P58
IPK2/2 and wild-type mice
were mock infected or infected with 10
3 PFU of the PR8 strain of
influenza virus. At 1, 3, and 5 days post infection, cardiac lung
lobes were excised and fixed in 10% neutral-buffered formalin.
Lobes were paraffin embedded, sectioned, and stained for
influenza virus NP. Bar=50 mm.
Found at: doi:10.1371/journal.ppat.1000438.s003 (6.35 MB TIF)
Figure S4 Caspase 3 is activated in mice lacking P58
IPK during
influenza virus infection. P58
IPK2/2 and wild-type mice were
mock infected or infected with 10
3 PFU of the PR8 strain of
influenza virus. At 1, 3, and 5 days post infection, cardiac lung
lobes were excised and fixed in 10% neutral-buffered formalin.
Lobes were paraffin embedded, sectioned, and stained for cleaved
caspase 3. Bar=50 mm.
Found at: doi:10.1371/journal.ppat.1000438.s004 (6.59 MB TIF)
Figure S5 Day 3 Gene Set Enrichment Analysis (GSEA) table.
Gene ontology categories are shown if there are 3 or more genes in
the category. Categories highlighted in grey represent those
discussed in the text.
Found at: doi:10.1371/journal.ppat.1000438.s005 (1.16 MB TIF)
Figure S6 Day 5 Gene Set Enrichment Analysis (GSEA) table.
Gene ontology categories are shown if there are 3 or more genes in
the category.
Found at: doi:10.1371/journal.ppat.1000438.s006 (1.22 MB TIF)
Figure S7 Day 1 Gene Set Enrichment Analysis (GSEA) table.
GSEA table from the analysis described in Figure 4. Gene
ontology categories are shown if there are 3 or more genes in the
category. Categories highlighted in grey are used for the analysis in
Figure 4.
Found at: doi:10.1371/journal.ppat.1000438.s007 (1.04 MB TIF)
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